Ceftriaxone & Tazobactam Injection 1.5 g Supplier for Abu Dhabi, United Arab Emirates
Advanced Sterile Antibiotic Injection Manufactured in India
Ernest Oncology presents Ceftriaxone & Tazobactam Injection 1.5 g, a premium sterile injectable antibiotic formulated with Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor. Manufactured in India under WHO-GMP certified facilities, this injectable medicine is produced with advanced pharmaceutical technology and strict quality systems to ensure consistent purity, safety, and effectiveness.
The formulation is intended for intramuscular (IM) or intravenous (IV) administration under the supervision of qualified healthcare professionals.
Product Description
Ceftriaxone & Tazobactam Injection 1.5 g combines the antibacterial activity of Ceftriaxone with the beta-lactamase inhibiting action of Tazobactam. This combination enhances antibacterial effectiveness by helping protect the antibiotic against bacterial beta-lactamase enzymes.
The medicine is formulated for administration through intramuscular (IM) or intravenous (IV) injection and should always be administered by qualified healthcare professionals.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 1.5 g |
| Active Ingredients | Ceftriaxone + Tazobactam |
| Dosage Form | Sterile Powder for Injection |
| Administration | Intramuscular (IM) / Intravenous (IV) |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Dual-action antibacterial formulation
- Broad-spectrum antibiotic combination
- Sterile powder for injection
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable formulation
- Reliable batch consistency
- Export-quality packaging
- International manufacturing standards
- Strict quality control procedures
Mechanism of Action
The formulation provides antibacterial activity through two complementary mechanisms.
- Ceftriaxone inhibits bacterial cell wall synthesis, resulting in bacterial cell destruction.
- Tazobactam inhibits beta-lactamase enzymes that may reduce antibiotic effectiveness, allowing Ceftriaxone to maintain its antibacterial activity.
Together, they provide broader antibacterial coverage against susceptible bacterial organisms.
Recommended Dosage
The dosage should always be prescribed by a qualified healthcare professional.
Treatment depends upon:
- Type of bacterial infection
- Severity of infection
- Patient age
- Body weight
- Kidney function
- Overall clinical assessment
This medicine should only be administered under professional medical supervision.
Side Effects
Some individuals may experience temporary side effects during treatment.
Possible reactions include:
- Pain at the injection site
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary changes in liver enzyme levels
Consult your healthcare provider if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Use only under qualified medical supervision.
- Inform your doctor about any allergies before treatment.
- Complete the prescribed antibiotic course.
- Follow medical instructions carefully.
- Do not use expired medicine.
- Keep out of reach of children.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in the original packaging
- Do not freeze.
- Use before the expiry date.
Quality Assurance
Every batch manufactured for Ernest Oncology is produced under internationally recognized pharmaceutical quality systems to ensure safety, purity, and consistency.
Our Quality Promise
- WHO-GMP certified manufacturing units
- Sterile production environment
- Comprehensive batch testing
- Product traceability
- Export-grade packaging
- Controlled storage practices
- Documentation verification
- Ongoing quality monitoring
Documentation
The following documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Ernest Oncology is dedicated to improving healthcare by delivering pharmaceutical products manufactured according to internationally accepted quality standards. Through scientific innovation, advanced production technologies, and a commitment to excellence, we continue to support better healthcare outcomes with dependable medicines manufactured in India.
Abu Dhabi Pharmaceutical Market Information
Abu Dhabi has established itself as one of the Middle East's leading healthcare destinations, supported by internationally accredited hospitals, advanced medical centres, and a rapidly growing pharmaceutical sector. The healthcare industry continues to prioritize medicines manufactured according to internationally recognized quality standards while ensuring patient safety and treatment reliability.
Indian pharmaceutical manufacturers are trusted worldwide for producing high-quality injectable medicines through advanced manufacturing technologies and internationally accepted quality management systems.
Why Choose Indian Pharmaceutical Exports
India is recognized globally for manufacturing high-quality pharmaceutical products that serve healthcare systems across more than 200 countries.
Benefits of Indian Pharmaceutical Manufacturing
- WHO-GMP certified manufacturing facilities
- Advanced sterile production technology
- International quality compliance
- High pharmaceutical purity
- Reliable manufacturing consistency
- Modern quality assurance systems
- Export-standard packaging
- Continuous quality monitoring
- Globally trusted manufacturing expertise
- Strong pharmaceutical innovation
